Chronic Fatigue Syndrome Trial, Recruiting NCT05168124 Sponsor: Sarah Schiebler Condition: Chronic Fatigue Syndrome
Back to Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Trial, Recruiting

NCT05168124
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
  • Your mental health condition has been stable for the past 3 months, meaning no change in your psychiatric diagnosis during that time
  • You have not been admitted to a psychiatric hospital or needed emergency psychiatric care in the past 3 months
  • You have not made a suicide attempt in the past 3 months
  • You have access to the internet
  • You are comfortable enough using electronic devices (such as a computer, tablet, or smartphone)
  • You are willing to take part in the specific therapies offered in this trial (called ACT and MBEL)

Who may not be able to join:

  • You do not have sufficient knowledge of the German language
  • You have a serious mental health condition such as personality disorders, PTSD, psychotic disorders, dissociative disorders, significant intellectual disability, or untreated ADHD, or you are currently having thoughts of suicide
  • You have an untreated or serious physical health condition, such as a thyroid problem or significant sleep apnea (confirm with trial site)
  • You have a heart condition such as chronic heart failure
  • You have a serious or untreated neurological condition, such as Parkinson's disease, dementia, restless legs syndrome, or narcolepsy
  • You are dependent on alcohol or drugs
  • You have recently started (within the past 3 months) taking psychiatric medication at a full treatment dose
  • You have started a new type of psychotherapy within the past 3 months
  • You are currently receiving other therapies such as acupuncture, qigong, or osteopathy
  • You have had certain physical treatments, cortisone treatment, or radio-/chemotherapy within the past 6 months (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0041 44 255 52 80

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sarah Schiebler
Registry
ClinicalTrials.gov
Start date
8 August 2023
Est. completion
1 December 2025

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Fatigue Severity Scale (FSS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov